Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Centre Oscar Lambret
Mayo Clinic
Eli Lilly and Company
QBiotics Group Limited
Kivu Bioscience Inc.
UMC Utrecht
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
ViroMissile, Inc.
Essen Biotech
M.D. Anderson Cancer Center
Angiex, Inc.
Hackensack Meridian Health
MacroGenics
UNC Lineberger Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Solve Therapeutics
National Cancer Institute (NCI)
Ocellaris Pharma, Inc.
Hoffmann-La Roche
Memorial Sloan Kettering Cancer Center
Institut National de la Santé Et de la Recherche Médicale, France
Memorial Sloan Kettering Cancer Center
UNICANCER
Transgene
Turning Point Therapeutics, Inc.
IDRx Inc. - A GSK Company
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut Bergonié
Institut Bergonié
Hadassah Medical Organization
Kazia Therapeutics Limited
Institut Bergonié
NextPoint Therapeutics, Inc.
Hutchmed
Elevation Oncology
IGM Biosciences, Inc.
University of California, San Francisco
Cedars-Sinai Medical Center
GI Innovation, Inc.
Actuate Therapeutics Inc.
Taiho Pharmaceutical Co., Ltd.
Sumitomo Pharma America, Inc.
Centre Leon Berard